Regen BioPharma Inc (RGBP)

[29YEARINVESTOR]

Wrong! If Lilly wants to extend the partnership or buyout!
We want hear about it until it’s a done deal. There would be a NDA IMO!
We do know that Lilly wanted RGBP to get the human Patent before any deal. That Human Patent has finally got FDA approval!
Now The sky is the limit!
https://www.hvst.com/posts/ongoing-agreement-with-eli-lilly-leads-to-discovery-of-several-new-small-molecule-drugs-wm4T1ZDp
Eli Lilly (LLY) & RGBP Partner in Small Molecules Immuno-Oncology - Autoimmunization NR2F6 Program. They Currently Await New Patents, Etc. News of Approval.
The Intended Result is Oral Drugs-Therapies-Treatment for Cancers & Auto Immune Diseases.
Specializing in Cutting Edge Technology.

https://www.otcmarkets.com/filing/html?id=15246005&guid=0UBwkePH2yzmJth

Check out the new patents that we have all been waiting for along with what Eli Lilly was waiting for from previous studies together!
The sky is the limit IMO!

$RGBP $RGBPP connection to $LLY (Eli Lilly one of the TOP pharmaceutical co in the world)
Jean-Pierre Millon was executive 23 years @ LLY and would not have been associated with Regen unless he knew the significance of NR2F6 imo
Connected to $CVS n GPP a $2.2 TRILLION hedge fund! pic.twitter.com/o0C7Hz8k3R

— ⚡️420⚡️ (@WZ_420) August 29, 2021

https://www.biospace.com/article/releases/regen-biopharma-inc-announces-former-eli-lilly-executive-and-current-cvs-board-member-will-lead-newly-formed-business-advisory-board-bab-/

https://www.prnewswire.com/news-releases/regen-biopharma-inc-enters-into-open-innovation-drug-discovery-program-agreement-with-eli-lilly-and-company-585014641.html